EUVIMEDEUVIMED entdecken
Open Access

STAT3 controls IL-6–induced epigenomic remodeling and restrains a latent STAT1-associated interferon program in human macrophages

Yebin Park iD, Geunho Kwon iD, Junho Noh iD, Jaehyun Lee iD, Keunsoo Kang iD, Kyung-Hyun Park-Min iD, Kyuho Kang iD

Science Advances · 13.11.2026 · 12 (46)

DOI: 10.1126/sciadv.aek8053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 13.11.2026. Verfasst von Yebin Park und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences and Biotechnology, Chungbuk National University, Cheongju 28644, Republic of Korea. Hauptthemen laut MEDLINE: Interleukin-6, STAT1 Transcription Factor, STAT3 Transcription Factor, Macrophages. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin-6 (IL-6) is a pleiotropic cytokine that drives macrophage functions ranging from tissue homeostasis to inflammation, yet how STAT3 specifies these divergent outcomes remains unclear. By integrating transcriptomic and epigenomic profiling with selective STAT3 degradation, we show that STAT3 controls IL-6–induced epigenomic remodeling and restrains a latent STAT1-associated interferon program in human macrophages. Graded STAT3 chromatin recruitment scales with locus-specific H3K27ac deposition and transcriptional output across homeostatic and inflammatory programs. STAT3 degradation permits STAT1 recruitment at a subset of regulatory regions and engages a delayed amplification loop that is partially dependent on STING and type I IFN signaling. In severe COVID-19, monocytes exhibit exaggerated STAT3-associated inflammatory signatures together with attenuated STAT1-associated interferon responses, consistent with a skewed STAT3-STAT1 balance. These findings define a framework in which STAT3 calibrates IL-6–induced chromatin output while maintaining pathway fidelity by limiting STAT1 cross-talk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-6STAT1 Transcription FactorSTAT3 Transcription FactorMacrophagesEpigenesis, GeneticInterferon Type IHumansSignal TransductionChromatin

Substanzen

Interleukin-6STAT1 Transcription FactorSTAT3 Transcription FactorSTAT1 protein, humanSTAT3 protein, humanChromatinInterferon Type I

Autor:innen und Institutionen

  • Department of Biological Sciences and Biotechnology, Chungbuk National University, Cheongju 28644, Republic of Korea.
  • Department of Microbiology, College of Science and Technology, Dankook University, Cheonan 31116, Republic of Korea.
  • Arthritis and Tissue Degeneration Program, David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY 10021, USA.
  • BCMB Allied Program, Weill Cornell Graduate School of Medical Sciences, New York, NY 10021, USA.
  • Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA.

ORCID-Profile: Yebin Park, Geunho Kwon, Junho Noh, Jaehyun Lee, Keunsoo Kang, Kyung-Hyun Park-Min, Kyuho Kang

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Park, Y., Kwon, G., Noh, J., Lee, J., Kang, K., Park-Min, K. H., & Kang, K. (2026). STAT3 controls IL-6–induced epigenomic remodeling and restrains a latent STAT1-associated interferon program in human macrophages. Science Advances, 12(46). https://doi.org/10.1126/sciadv.aek8053

Vancouver

Park Y, Kwon G, Noh J, Lee J, Kang K, Park-Min KH, et al. STAT3 controls IL-6–induced epigenomic remodeling and restrains a latent STAT1-associated interferon program in human macrophages. Science Advances. 2026;12(46). doi:10.1126/sciadv.aek8053

BibTeX
@article{Park2026,
  author = {Park, Yebin and Kwon, Geunho and Noh, Junho and Lee, Jaehyun and Kang, Keunsoo and Park-Min, Kyung-Hyun and Kang, Kyuho},
  title = {STAT3 controls IL-6–induced epigenomic remodeling and restrains a latent STAT1-associated interferon program in human macrophages},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {46},
  doi = {10.1126/sciadv.aek8053}
}
Kostenlos starten →